What is NDC 71921-150?

71921-150 is the product NDC for Mercaptopurine, Mercaptopurine 50 mg/1 tablet, listed with the FDA by Florida Pharmaceutical Products, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Florida Pharmaceutical Products, LLC, NDC labeler code 71921. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Mercaptopurine?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Mercaptopurine NDC 71921-150 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71921-150Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71921-0150Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71921-150-02	7192101500271921015002	25 TABLET in 1 BOTTLE (71921-150-02)Marketed from Jan 30, 2026
71921-150-25	7192101502571921015025	250 TABLET in 1 BOTTLE (71921-150-25)Marketed from Jan 30, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mercaptopurine
Generic name (nonproprietary): mercaptopurine
Active ingredients: Mercaptopurine — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Florida Pharmaceutical Products, LLCNDC labeler code 71921
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 009053
Marketing start: Jan 30, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Nucleic Acid Synthesis Inhibitors (Mechanism)
Identifiers: Product ID 71921-150_e7309808-5ae8-4a55-90e3-3992ace0da62SPL ID e7309808-5ae8-4a55-90e3-3992ace0da62SPL set ID e7309808-5ae8-4a55-90e3-3992ace0da62RxCUI 197931UNII E7WED276I5UPC 0371921150250, 0371921150021
Pharmacologic class: Nucleoside Metabolic Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471921015002 followed by a unit qualifier and the quantity

Package 71921-0150-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 30, 2026.

Indications (excerpt from the label)

Mercaptopurine tablets is a nucleoside metabolic inhibitor indicated for treatment of adult and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen. (1.1) 1.1 Acute Lymphoblastic Leukemia Mercaptopurine tablets are indicated for treatment of adult and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71921-150

What is NDC 71921-150?: 71921-150 is the product NDC for Mercaptopurine, Mercaptopurine 50 mg/1 tablet, listed with the FDA by Florida Pharmaceutical Products, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Mercaptopurine.
What is the active ingredient?: Mercaptopurine.
Who is the labeler?: Florida Pharmaceutical Products, LLC, NDC labeler code 71921. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Mercaptopurine?: 5 other product NDCs are listed under this name. See all Mercaptopurine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Mercaptopurine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Mercaptopurine	Mercaptopurine 20 mg/mL	SuspensionOral	Nova Laboratories, Ltd	62484-1020	62484-1020-04
Mercaptopurine	Mercaptopurine 20 mg/mL	SuspensionOral	Hikma Pharmaceuticals USA Inc.	0054-0879	00054-0879-49
Mercaptopurine	Mercaptopurine 20 mg/mL	SuspensionOral	Hikma Pharmaceuticals USA Inc.	0054-4582	00054-4582-49
Mercaptopurine	Mercaptopurine 50 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-4581	00054-4581-1100054-4581-27
Mercaptopurine	Mercaptopurine 50 mg/1	TabletOral	Golden State Medical Supply, Inc.	51407-983	51407-0983-25